Login/Sign Up
₹24203.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Ivzumab 100 mg Injection 4 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.
Ivzumab 100 mg Injection 4 ml contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Ivzumab 100 mg Injection 4 ml will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Ivzumab 100 mg Injection 4 ml may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen
Avoid taking Ivzumab 100 mg Injection 4 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Ivzumab 100 mg Injection 4 ml may cause sleepiness and fainting, so avoid driving while on treatment with Ivzumab 100 mg Injection 4 ml. Do not breastfeed during the treatment and for 6months after the last dose of Ivzumab 100 mg Injection 4 ml. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.
Ivzumab 100 mg Injection 4 ml is used in the treatment of Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, and cancer of the colon and rectum. The detailed uses of Ivzumab 100 mg Injection 4 ml are as follows:
Ivzumab 100 mg Injection 4 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Ivzumab 100 mg Injection 4 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
Unsafe
You are recommended to avoid alcohol consumption while taking Ivzumab 100 mg Injection 4 ml. It could lead to unpleasant side effects.
Unsafe
Ivzumab 100 mg Injection 4 ml should not be used during pregnancy because it causes harm to the fetus. Women of childbearing potential must use an effective contraception method while taking Ivzumab 100 mg Injection 4 ml and at least six months after the last dose. Please consult your doctor about any concerns regarding this.
Unsafe
Avoid breastfeeding during treatment and for 6months after the last dose. This is due to the possibility of the medication being passed on to the infant through breast milk.
Caution
Caution should be exercised when driving or operating machinery because in some cases, Ivzumab 100 mg Injection 4 ml may cause sleepiness and fainting.
Caution
If you have/had a history of any liver-related diseases, please inform the doctor before taking Ivzumab 100 mg Injection 4 ml. Your doctor will weigh the benefits and potential risks before prescribing Ivzumab 100 mg Injection 4 ml.
Caution
If you have/had a history of any kidney-related diseases, please inform the doctor before taking Ivzumab 100 mg Injection 4 ml. Your doctor will weigh the benefits and potential risks before prescribing Ivzumab 100 mg Injection 4 ml.
Unsafe
Ivzumab 100 mg Injection 4 ml is not recommended for children below 18years as the safety and effectiveness have not been established.
Caution
Ivzumab 100 mg Injection 4 ml should be administered with caution in patients with heart problems. Please inform your doctor if you have any pre-existing heart problems before receiving Ivzumab 100 mg Injection 4 ml.
Caution
Ivzumab 100 mg Injection 4 ml should be administered with caution in older adults. please seek medical advice before receiving it.
Have a query?
Ivzumab 100 mg Injection 4 ml should only be taken under medical supervision. While taking Ivzumab 100 mg Injection 4 ml, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to Ivzumab 100 mg Injection 4 ml or other medications, inform your doctor before taking it. Avoid taking Ivzumab 100 mg Injection 4 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Ivzumab 100 mg Injection 4 ml may cause sleepiness and fainting, so avoid driving while on treatment with Ivzumab 100 mg Injection 4 ml. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of Ivzumab 100 mg Injection 4 ml. While taking Ivzumab 100 mg Injection 4 ml, please do not get any immunizations or vaccinations unless your doctor has approved it. Ivzumab 100 mg Injection 4 ml may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.
Drug-Drug Interactions: Ivzumab 100 mg Injection 4 ml may have interaction with a drug used to treat renal and gastrointestinal cancer (sunitinib) and platinum or taxane-based therapies for lung or metastatic breast cancer. Inform your doctor if you have recently received, or are receiving, radiotherapy.
Drug-Food Interactions: Avoid the consumption of alcohol while taking Ivzumab 100 mg Injection 4 ml.
Drug-Disease Interactions: Inform your doctor if you have/had infections, bleeding disorders, fistula formation (an abnormal connection between two body parts), GI perforation, hypertension, PRES (Posterior Reversible Encephalopathy Syndrome), proteinuria (abnormal quantities of protein in the urine), and thromboembolic disorders.
Login/Sign Up
Login/Sign Up
Celon Laboratories Pvt Ltd
₹7500
(₹1875.0/ 1ml)
Plasmagen Biosciences Pvt Ltd
₹13500
(₹3375.0/ 1ml)
Abbott India Ltd
₹59277
(₹3704.81/ 1ml)
Disclaimer

RX